"F-18 DOPA (3,4-dihydroxy-6-[18F]fluoro-L-phenylalanine) is a PET radiotracer primarily used in the evaluation of neuropsychiatric diseases, movement disorders, and brain malignancies 1."
Expected headings
"Production"
"Clinical uses"
"F-18 DOPA has mainly been used in the assessment of Parkinson disease 2, schizophrenia and gliomas 4. It is also used for phaeochromocytoma, extra-adrenal abdominal paraganglioma and congenital hyperinsulinaemia 3,5,6."